Skip to main content
Erschienen in: International Journal of Diabetes in Developing Countries 3/2019

18.12.2018 | Original Article

Clinical, radiological, and histological characteristics of Chinese type 2 diabetic patients with diabetic scleredema: an observational study

verfasst von: Yingying Zhou, Chaoming Wu, Zhijuan Dai, Jian Jin, Yaoxin Zhu, Yanying Qian

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Diabetic scleredema (DS) is reported rarely in China and its features are poorly documented. We aim to describe the characteristics of Chinese patients with DS clinically, radiologically, and histologically.

Methods

Of 9825 hospitalized participants with diabetes older than 18 years, 15 type 2 diabetes patients with DS as well as 15 non-DS patients with type 2 diabetes were included in this observational study.

Results

All the individuals with DS presented diffuse erythema, non-pitting, and painless indurations on the skin of the nape and upper back. Patients with DS were mainly middle-aged or elderly (male to female ratio, 4:1), with long-standing poorly controlled type 2 diabetes, overweight, or obese. Patients with DS vs non-DS had a higher prevalence of diabetic microvascular complications, neuropathy, hypertension, cerebral infarction, nicotine abuse, and alcohol abuse. LDL-C level was significantly higher in the DS group (p = 0.0143), and the skin and subcutaneous fat in T2-weighted MRI were significantly thickened in the DS group than in the non-DS group (p < 0.01). Skin biopsies showed thickened collagen bundles throughout the dermis and active fibroblast proliferation.

Conclusion

Our reports suggest that DS is relatively rare in Chinese patients with diabetes. DS occurs both in middle-aged and elderly patients (male predominantly), overweight or obese, having long-term poorly controlled type 2 diabetes, and presenting a high incidence of microvascular complications, hypertension, neuropathy, and ischemic cerebral stroke. High LDL-C level, nicotine abuse, and alcohol abuse may be risk factors. MRI could be preferable to assess the severity of DS non-invasively.
Literatur
1.
Zurück zum Zitat Murphy-Chutorian B, Han G, Cohen SR. Dermatologic manifestations of diabetes mellitus: a review. Endocrinol Metab Clin N Am. 2013;42:869–98.CrossRef Murphy-Chutorian B, Han G, Cohen SR. Dermatologic manifestations of diabetes mellitus: a review. Endocrinol Metab Clin N Am. 2013;42:869–98.CrossRef
2.
3.
Zurück zum Zitat Cole GW, Headley J, Skowsky R. Scleredema diabeticorum: a common and distinct cutaneous manifestation of diabetes mellitus. Diabetes Care. 1983;6:189–92.CrossRefPubMed Cole GW, Headley J, Skowsky R. Scleredema diabeticorum: a common and distinct cutaneous manifestation of diabetes mellitus. Diabetes Care. 1983;6:189–92.CrossRefPubMed
4.
Zurück zum Zitat Martin C, Requena L, Manrique K, Manzarbeitia FD, Rovira A. Scleredema diabeticorum in a patient with type 2 diabetes mellitus. Case Rep Endocrinol. 2011;2011:560273.PubMedPubMedCentral Martin C, Requena L, Manrique K, Manzarbeitia FD, Rovira A. Scleredema diabeticorum in a patient with type 2 diabetes mellitus. Case Rep Endocrinol. 2011;2011:560273.PubMedPubMedCentral
5.
Zurück zum Zitat Chatterjee S. Neck pain, stiffness, and periorbital edema in a man with diabetes. Jama. 2016;315:1159–60.CrossRefPubMed Chatterjee S. Neck pain, stiffness, and periorbital edema in a man with diabetes. Jama. 2016;315:1159–60.CrossRefPubMed
6.
Zurück zum Zitat Miyares FJ, Kuriakose R, Deleu DT, El-Wahad NA, Al-Hail H. Scleredema diabeticorum with unusual presentation and fatal outcome. Indian J Dermatol. 2008;53:217–9.CrossRefPubMedPubMedCentral Miyares FJ, Kuriakose R, Deleu DT, El-Wahad NA, Al-Hail H. Scleredema diabeticorum with unusual presentation and fatal outcome. Indian J Dermatol. 2008;53:217–9.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Wilson BE, Newmark JJ. Severe scleredema diabeticorum and insulin resistance. J Am Board Fam Pract. 1995;8:55–7.PubMed Wilson BE, Newmark JJ. Severe scleredema diabeticorum and insulin resistance. J Am Board Fam Pract. 1995;8:55–7.PubMed
8.
Zurück zum Zitat Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362:1090–101.CrossRefPubMed Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362:1090–101.CrossRefPubMed
9.
10.
Zurück zum Zitat Kobayashi T, Yamasaki Y, Watanabe T. Diabetic scleredema: a case report and biochemical analysis for glycosaminoglycans. J Dermatol. 1997;24:100–3.CrossRefPubMed Kobayashi T, Yamasaki Y, Watanabe T. Diabetic scleredema: a case report and biochemical analysis for glycosaminoglycans. J Dermatol. 1997;24:100–3.CrossRefPubMed
11.
Zurück zum Zitat Nakajima K, Iwagaki M, Ikeda M, Kodama H. Two cases of diabetic scleredema that responded to PUVA therapy. J Dermatol. 2006;33:820–2.CrossRefPubMed Nakajima K, Iwagaki M, Ikeda M, Kodama H. Two cases of diabetic scleredema that responded to PUVA therapy. J Dermatol. 2006;33:820–2.CrossRefPubMed
12.
Zurück zum Zitat Koga N. Beneficial effect of aggressive low-density lipoprotein apheresis in a familial hypercholesterolemic patient with severe diabetic scleredema. Ther Apher. 2001;5:506–12.CrossRefPubMed Koga N. Beneficial effect of aggressive low-density lipoprotein apheresis in a familial hypercholesterolemic patient with severe diabetic scleredema. Ther Apher. 2001;5:506–12.CrossRefPubMed
13.
Zurück zum Zitat Koga N. Effects of low-density lipoprotein apheresis on coronary and carotid atherosclerosis and diabetic scleredema in patients with severe hypercholesterolemia. Ther Apher. 2001;5:244–51.CrossRefPubMed Koga N. Effects of low-density lipoprotein apheresis on coronary and carotid atherosclerosis and diabetic scleredema in patients with severe hypercholesterolemia. Ther Apher. 2001;5:244–51.CrossRefPubMed
14.
Zurück zum Zitat Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988;318:1315–21.CrossRefPubMed Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988;318:1315–21.CrossRefPubMed
15.
Zurück zum Zitat Rongioletti F, Kaiser F, Cinotti E, Metze D, Battistella M, Calzavara-Pinton PG, et al. Scleredema. A multicentre study of characteristics, comorbidities, course and therapy in 44 patients. J Eur Acad Dermatol Venereol. 2015;29:2399–404.CrossRefPubMed Rongioletti F, Kaiser F, Cinotti E, Metze D, Battistella M, Calzavara-Pinton PG, et al. Scleredema. A multicentre study of characteristics, comorbidities, course and therapy in 44 patients. J Eur Acad Dermatol Venereol. 2015;29:2399–404.CrossRefPubMed
16.
Zurück zum Zitat Sternberg M, Urios P, Grigorova-Borsos AM. Effects of glycation process on the macromolecular structure of the glomerular basement membranes and on the glomerular functions in aging and diabetes mellitus. C R Seances Soc Biol Fil. 1995;189:967–85.PubMed Sternberg M, Urios P, Grigorova-Borsos AM. Effects of glycation process on the macromolecular structure of the glomerular basement membranes and on the glomerular functions in aging and diabetes mellitus. C R Seances Soc Biol Fil. 1995;189:967–85.PubMed
17.
Zurück zum Zitat Chvapil M, Hurych J. Control of collagen biosynthesis. Int Rev Connect Tissue Res. 1968;4:67–196.CrossRefPubMed Chvapil M, Hurych J. Control of collagen biosynthesis. Int Rev Connect Tissue Res. 1968;4:67–196.CrossRefPubMed
18.
Zurück zum Zitat Ikeda Y, Suehiro T, Abe T, Yoshida T, Shinoki T, Tahara K, et al. Severe diabetic scleredema with extension to the extremities and effective treatment using prostaglandin E1. Intern Med. 1998;37:861–4.CrossRefPubMed Ikeda Y, Suehiro T, Abe T, Yoshida T, Shinoki T, Tahara K, et al. Severe diabetic scleredema with extension to the extremities and effective treatment using prostaglandin E1. Intern Med. 1998;37:861–4.CrossRefPubMed
19.
Zurück zum Zitat Mattheou-Vakali G, Ioannides D, Thomas T, Lazaridou E, Tsogas P, Minas A. Cyclosporine in scleredema. J Am Acad Dermatol. 1996;35:990–1.CrossRefPubMed Mattheou-Vakali G, Ioannides D, Thomas T, Lazaridou E, Tsogas P, Minas A. Cyclosporine in scleredema. J Am Acad Dermatol. 1996;35:990–1.CrossRefPubMed
20.
Zurück zum Zitat Dogramaci AC, Inan MU, Atik E, Gokce C. Scleredema diabeticorum partially treated with low-dose methotrexate: a report of five cases. Balkan Med J. 2012;29:218–21.CrossRefPubMedPubMedCentral Dogramaci AC, Inan MU, Atik E, Gokce C. Scleredema diabeticorum partially treated with low-dose methotrexate: a report of five cases. Balkan Med J. 2012;29:218–21.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Breuckmann F, Appelhans C, Harati A, Rotterdam S, Altmeyer P, Kreuter A. Failure of low-dose methotrexate in the treatment of scleredema diabeticorum in seven cases. Dermatology. 2005;211:299–301.CrossRefPubMed Breuckmann F, Appelhans C, Harati A, Rotterdam S, Altmeyer P, Kreuter A. Failure of low-dose methotrexate in the treatment of scleredema diabeticorum in seven cases. Dermatology. 2005;211:299–301.CrossRefPubMed
22.
Zurück zum Zitat Matsuura K, Umebayashi Y, Otsuka F. Computed tomography reveals thickened subcutaneous tissue in scleroedema. Br J Dermatol. 1997;137:1015–6.CrossRefPubMed Matsuura K, Umebayashi Y, Otsuka F. Computed tomography reveals thickened subcutaneous tissue in scleroedema. Br J Dermatol. 1997;137:1015–6.CrossRefPubMed
23.
Zurück zum Zitat Cole GW, Handler SJ, Burnett K. The ultrasonic evaluation of skin thickness in scleredema. J Clin Ultrasound. 1981;9:501–3.CrossRefPubMed Cole GW, Handler SJ, Burnett K. The ultrasonic evaluation of skin thickness in scleredema. J Clin Ultrasound. 1981;9:501–3.CrossRefPubMed
24.
Zurück zum Zitat Blaicher W, Prayer D, Bernaschek G. Magnetic resonance imaging and ultrasound in the assessment of the fetal central nervous system. J Perinat Med. 2003;31:459–68.CrossRefPubMed Blaicher W, Prayer D, Bernaschek G. Magnetic resonance imaging and ultrasound in the assessment of the fetal central nervous system. J Perinat Med. 2003;31:459–68.CrossRefPubMed
25.
Zurück zum Zitat Kokpol C, Rajatanavin N, Rattanakemakorn P. Successful treatment of scleredema diabeticorum by combining local PUVA and colchicine: a case report. Case Rep Dermatol. 2012;4:265–8.CrossRefPubMedPubMedCentral Kokpol C, Rajatanavin N, Rattanakemakorn P. Successful treatment of scleredema diabeticorum by combining local PUVA and colchicine: a case report. Case Rep Dermatol. 2012;4:265–8.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Thumpimukvatana N, Wongpraparut C, Lim HW. Scleredema diabeticorum successfully treated with ultraviolet A1 phototherapy. J Dermatol. 2010;37:1036–9.CrossRefPubMed Thumpimukvatana N, Wongpraparut C, Lim HW. Scleredema diabeticorum successfully treated with ultraviolet A1 phototherapy. J Dermatol. 2010;37:1036–9.CrossRefPubMed
27.
Zurück zum Zitat Alsaeedi SH, Lee P. Treatment of scleredema diabeticorum with tamoxifen. J Rheumatol. 2010;37:2636–7.CrossRefPubMed Alsaeedi SH, Lee P. Treatment of scleredema diabeticorum with tamoxifen. J Rheumatol. 2010;37:2636–7.CrossRefPubMed
Metadaten
Titel
Clinical, radiological, and histological characteristics of Chinese type 2 diabetic patients with diabetic scleredema: an observational study
verfasst von
Yingying Zhou
Chaoming Wu
Zhijuan Dai
Jian Jin
Yaoxin Zhu
Yanying Qian
Publikationsdatum
18.12.2018
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 3/2019
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-018-0705-3

Weitere Artikel der Ausgabe 3/2019

International Journal of Diabetes in Developing Countries 3/2019 Zur Ausgabe